Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen Johnson

Showing results (101-110 of 110) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 110 results.
Clinical Lymphoma & Myeloma|April 28, 2006
Update on recommendations for assessing response from the Third International Workshop on Waldenstrom's MacroglobulinemiaEva Kimby, Steven P Treon, Athanasios Anagnostopoulos, et al.
Blood|January 18, 2006
Update on treatment recommendations from the Third International Workshop on Waldenstrom's macroglobulinemiaSteven P Treon, Morie A Gertz, Meletios Dimopoulos, et al.
Plos One|December 1, 2017
A comprehensive analysis of breast cancer microbiota and host gene expressionKevin J Thompson, James N Ingle, Xiaojia Tang, et al.
Biorxiv : the Preprint Server for Biology|December 23, 2024
Gut Microbiome Signatures During Acute Infection Predict Long COVIDIsin Y Comba, Ruben A T Mars, Lu Yang, et al.
Cardiovascular Drugs and Therapy|July 6, 2020
Next-Generation Sequencing of CYP2C19 in Stent Thrombosis: Implications for Clopidogrel PharmacogenomicsJoel A Morales-Rosado, Kashish Goel, Lingxin Zhang, et al.
Science (New York, N.Y.)|September 21, 2002
BLM heterozygosity and the risk of colorectal cancerStephen B Gruber, Nathan A Ellis, Karen K Scott, et al.
Journal for Immunotherapy of Cancer|April 15, 2025
Neoadjuvant cobimetinib and atezolizumab with or without vemurafenib for stage III melanoma: outcomes and the impact of the microbiome from the NeoACTIVATE trialMatthew S Block, Garth D Nelson, Jun Chen, et al.
Cancers|May 14, 2022
Potential Role of Inflammation-Promoting Biliary Microbiome in Primary Sclerosing Cholangitis and CholangiocarcinomaKatsuyuki Miyabe, Vinay Chandrasekhara, Nicha Wongjarupong, et al.
JAMA Network Open|August 13, 2025
Evaluating Hospital Course Summarization by an Electronic Health Record-Based Large Language ModelWilliam R Small, Jonathan Austrian, Luke O'Donnell, et al.
Gut Microbes|April 13, 2026
Compositional and functional differences of gut microbiome and metabolome inform pathogenesis of cholestatic liver diseaseMarios Nikolaidis, Chang Hu, Brian D Juran, et al.
Pageof 11

Showing results (101-110 of 110) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 110 results.
Clinical Lymphoma & Myeloma|April 28, 2006
Update on recommendations for assessing response from the Third International Workshop on Waldenstrom's MacroglobulinemiaEva Kimby, Steven P Treon, Athanasios Anagnostopoulos, et al.
Blood|January 18, 2006
Update on treatment recommendations from the Third International Workshop on Waldenstrom's macroglobulinemiaSteven P Treon, Morie A Gertz, Meletios Dimopoulos, et al.
Plos One|December 1, 2017
A comprehensive analysis of breast cancer microbiota and host gene expressionKevin J Thompson, James N Ingle, Xiaojia Tang, et al.
Biorxiv : the Preprint Server for Biology|December 23, 2024
Gut Microbiome Signatures During Acute Infection Predict Long COVIDIsin Y Comba, Ruben A T Mars, Lu Yang, et al.
Cardiovascular Drugs and Therapy|July 6, 2020
Next-Generation Sequencing of CYP2C19 in Stent Thrombosis: Implications for Clopidogrel PharmacogenomicsJoel A Morales-Rosado, Kashish Goel, Lingxin Zhang, et al.
Science (New York, N.Y.)|September 21, 2002
BLM heterozygosity and the risk of colorectal cancerStephen B Gruber, Nathan A Ellis, Karen K Scott, et al.
Journal for Immunotherapy of Cancer|April 15, 2025
Neoadjuvant cobimetinib and atezolizumab with or without vemurafenib for stage III melanoma: outcomes and the impact of the microbiome from the NeoACTIVATE trialMatthew S Block, Garth D Nelson, Jun Chen, et al.
Cancers|May 14, 2022
Potential Role of Inflammation-Promoting Biliary Microbiome in Primary Sclerosing Cholangitis and CholangiocarcinomaKatsuyuki Miyabe, Vinay Chandrasekhara, Nicha Wongjarupong, et al.
JAMA Network Open|August 13, 2025
Evaluating Hospital Course Summarization by an Electronic Health Record-Based Large Language ModelWilliam R Small, Jonathan Austrian, Luke O'Donnell, et al.
Gut Microbes|April 13, 2026
Compositional and functional differences of gut microbiome and metabolome inform pathogenesis of cholestatic liver diseaseMarios Nikolaidis, Chang Hu, Brian D Juran, et al.
Pageof 11